Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol for a Randomized, Controlled Study to Compare the Use of Gonodotropin-releasing Hormone Agonist Triptoreline (Gonapeptyl®) for Luteal Phase Support Versus Natural Luteal Phase in the Insemination Cycles

NCT03115307 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT03115307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03115307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol for a Randomized, Controlled Study to Compare the Use of Gonodotropin-releasing Hormone Agonist Triptoreline (Gonapeptyl®) for Luteal Phase Support Versus Natural Luteal Phase in the Insemination Cycles
Lead sponsor
Tampere University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
November 30, 2019
Enrollment
167 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female